iShares Biotechnology ETF (IBB) experienced an approximate $197.4 million outflow, a 2.4% decline week-over-week. The flow suggests short-term risk-off positioning in biotech ETFs but is unlikely to have broad market impact beyond sector positioning shifts.
iShares Biotechnology ETF (IBB) experienced an approximate $197.4 million outflow, a 2.4% decline week-over-week. The flow suggests short-term risk-off positioning in biotech ETFs but is unlikely to have broad market impact beyond sector positioning shifts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
